215 related articles for article (PubMed ID: 10078579)
1. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia.
Schjetlein R; Abdelnoor M; Haugen G; Husby H; Sandset PM; Wisløff F
Acta Obstet Gynecol Scand; 1999 Mar; 78(3):191-7. PubMed ID: 10078579
[TBL] [Abstract][Full Text] [Related]
2. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia.
Estellés A; Gilabert J; Grancha S; Yamamoto K; Thinnes T; España F; Aznar J; Loskutoff DJ
Thromb Haemost; 1998 Mar; 79(3):500-8. PubMed ID: 9580327
[TBL] [Abstract][Full Text] [Related]
3. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
4. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation.
Schjetlein R; Haugen G; Wisløff F
Acta Obstet Gynecol Scand; 1997 Jul; 76(6):541-6. PubMed ID: 9246959
[TBL] [Abstract][Full Text] [Related]
5. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia.
Kanfer A; Bruch JF; Nguyen G; He CJ; Delarue F; Flahault A; Nessmann C; Uzan S
Lab Invest; 1996 Jan; 74(1):253-8. PubMed ID: 8569189
[TBL] [Abstract][Full Text] [Related]
6. [Hemostatic system parameters of placental extracts in normal pregnancy and severe preeclampsia].
López-Ramírez Y; Carvajal Z; Arocha-Piñango CL
Invest Clin; 2006 Sep; 47(3):233-40. PubMed ID: 17672283
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.
Kovo M; Schreiber L; Elyashiv O; Ben-Haroush A; Abraham G; Bar J
Reprod Sci; 2015 Mar; 22(3):316-21. PubMed ID: 25001023
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
9. Uteroplacental hemostasis in intrauterine fetal growth retardation.
Sheppard BL; Bonnar J
Semin Thromb Hemost; 1999; 25(5):443-6. PubMed ID: 10625199
[TBL] [Abstract][Full Text] [Related]
10. Differential release of plasminogen activator inhibitors (PAIs) during dual perfusion of human placenta: implications in preeclampsia.
Guller S; Ma Y; Malek A; Di Santo S; Schneider H
Placenta; 2007 Apr; 28(4):278-85. PubMed ID: 16820203
[TBL] [Abstract][Full Text] [Related]
11. Changes of plasma and placental tissue factor pathway inhibitor-2 in women with preeclampsia and normal pregnancy.
Xiong Y; Zhou Q; Jiang F; Zhou S; Lou Y; Guo Q; Liang W; Kong D; Ma D; Li X
Thromb Res; 2010 Jun; 125(6):e317-22. PubMed ID: 20347477
[TBL] [Abstract][Full Text] [Related]
12. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies.
Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; Patricio B; Quintanilha A; Santos-Silva A
Thromb Res; 2008; 123(2):219-24. PubMed ID: 18384840
[TBL] [Abstract][Full Text] [Related]
13. Pre-pregnant prediction of recurrent preeclampsia in normotensive thrombophilic formerly preeclamptic women receiving prophylactic antithrombotic medication.
Spaanderman ME; Aardenburg R; Ekhart TH; van Eyndhoven HW; de Leeuw PW; Peeters LL
J Soc Gynecol Investig; 2005 Feb; 12(2):112-7. PubMed ID: 15695106
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of the hemostasis parameters in the development of preeclampsia.
Ho CH; Yang ZL
Thromb Haemost; 1992 Feb; 67(2):214-8. PubMed ID: 1621241
[TBL] [Abstract][Full Text] [Related]
15. Prediction of maternal and fetal complications in preeclampsia.
Nisell H; Palm K; Wolff K
Acta Obstet Gynecol Scand; 2000 Jan; 79(1):19-23. PubMed ID: 10646811
[TBL] [Abstract][Full Text] [Related]
16. Involvement of fibrinolytic factors in mid trimester amniotic fluid with development of severe early-onset preeclampsia.
Adachi T; Nakabayashi M; Sakura M; Ando K
Semin Thromb Hemost; 1999; 25(5):447-50. PubMed ID: 10625200
[TBL] [Abstract][Full Text] [Related]
17. Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia.
Wikström AK; Nash P; Eriksson UJ; Olovsson MH
Am J Obstet Gynecol; 2009 Dec; 201(6):597.e1-8. PubMed ID: 19683696
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of PAI-2 mRNA and protein in pregnancies complicated with intrauterine fetal growth retardation.
Grancha S; Estellés A; Gilabert J; Chirivella M; España F; Aznar J
Thromb Haemost; 1996 Nov; 76(5):761-7. PubMed ID: 8950787
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
